Back to top


  /    /  Parsimony

Non-small-cell lung cancer (NSCLC) stage III treated with concurrent chemoradiation followed or not by consolidation chemotherapy.

Type of Study: Epidemiological

Sponsor / Support: LACOG, GBOT

Primary Objectives: Evaluate the impact of consolidation chemotherapy on overall survival of patients with locally advanced NSCLC undergoing definitive treatment with concomitant chemoradiotherapy

Design: Retrospective cohort study, multi-institutional.

Sample Size: 165 patients

Principal Investigator: Vladmir Cláudio Cordeiro de Lima , Gilberto de Castro Junior, Mauro Zukin, Clarissa Mathias.

Countries LATAM: Brazil